Pneumococcal Polysaccharide Powder Type 6A (US Type 6)
271-X ™
Purified pneumococcal polysaccharide type 6A (US Type 6) is manufactured by Pfizer, Inc., for small-quantity distribution by ATCC. The pneumococcal powder type 6A is a component of the current 13-valent vaccine against Streptococcus pneumoniae.
The pneumococcal polysaccharide type 6A can be used to assay for type-specific antibodies, research immune responses, and study immunodeficiencies.